Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Balaxi Pharmaceuticals Statistics

Total Valuation

NSE:BALAXI has a market cap or net worth of INR 1.32 billion. The enterprise value is 1.50 billion.

Market Cap	1.32B
Enterprise Value	1.50B

Important Dates

The last earnings date was Wednesday, January 28, 2026.

Earnings Date	Jan 28, 2026
Ex-Dividend Date	n/a

Share Statistics

NSE:BALAXI has 55.21 million shares outstanding. The number of shares has decreased by -0.91% in one year.

Current Share Class	55.21M
Shares Outstanding	55.21M
Shares Change (YoY)	-0.91%
Shares Change (QoQ)	-2.71%
Owned by Insiders (%)	4.53%
Owned by Institutions (%)	n/a
Float	9.57M

Valuation Ratios

The trailing PE ratio is 13.74.

PE Ratio	13.74
Forward PE	n/a
PS Ratio	0.48
PB Ratio	0.56
P/TBV Ratio	0.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	15.89
EV / Sales	0.54
EV / EBITDA	7.29
EV / EBIT	7.90
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.24
Debt / EBITDA	2.74
Debt / FCF	n/a
Interest Coverage	5.20

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	5.17%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	6.61%
Revenue Per Employee	4.60M
Profits Per Employee	157,363
Employee Count	600
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NSE:BALAXI has paid 41.11 million in taxes.

Income Tax	41.11M
Effective Tax Rate	30.33%

Stock Price Statistics

The stock price has decreased by -66.15% in the last 52 weeks. The beta is 0.59, so NSE:BALAXI's price volatility has been lower than the market average.

Beta (5Y)	0.59
52-Week Price Change	-66.15%
50-Day Moving Average	28.68
200-Day Moving Average	43.05
Relative Strength Index (RSI)	39.80
Average Volume (20 Days)	126,773

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:BALAXI had revenue of INR 2.76 billion and earned 94.42 million in profits. Earnings per share was 1.75.

Revenue	2.76B
Gross Profit	1.26B
Operating Income	189.92M
Pretax Income	135.53M
Net Income	94.42M
EBITDA	204.10M
EBIT	189.92M
Earnings Per Share (EPS)	1.75

Balance Sheet

The company has 388.49 million in cash and 565.23 million in debt, with a net cash position of -176.74 million or -3.20 per share.

Cash & Cash Equivalents	388.49M
Total Debt	565.23M
Net Cash	-176.74M
Net Cash Per Share	-3.20
Equity (Book Value)	2.38B
Book Value Per Share	45.56
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 45.55%, with operating and profit margins of 6.89% and 3.42%.

Gross Margin	45.55%
Operating Margin	6.89%
Pretax Margin	4.92%
Profit Margin	3.42%
EBITDA Margin	7.40%
EBIT Margin	6.89%
FCF Margin	n/a

Dividends & Yields

NSE:BALAXI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.91%
Shareholder Yield	0.91%
Earnings Yield	7.13%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on May 30, 2024. It was a forward split with a ratio of 5.

Last Split Date	May 30, 2024
Split Type	Forward
Split Ratio	5

Scores

Altman Z-Score	n/a
Piotroski F-Score	2